1. Ada GL, Jones PD (1986) The immune response to influenza infection. Curr Top Microbiol Immunol 128: 1–54
2. Aissaoui A, Klingel SI, Couderc J, Chateau D, Romagne F, Jambou F, Vincent A, Levasseur P, Eymard B, Maillot MC, Galanaud P, Berrih AS, Cohen KS (1999) Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis [see comments]. Ann Neurol 46: 559–567
3. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160: 624–633
4. Algeciras SA, Griffith TS, Lynch DH, Paya CV (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 162: 5205–5211
5. Alvarez VL, Agha MS, Hawkins RE, Russell SJ (1997) Pharmacological control of antigen responsiveness in genetically modified T lymphocytes. J Immunol 159: 5889–5895